Brain chemical targeted to unfreeze Parkinson's walk
NCT ID NCT07316296
Summary
This study is testing if the drug atomoxetine can help reduce 'freezing of gait'—a sudden, temporary inability to move the feet—in people with Parkinson's disease. Researchers will compare atomoxetine to a placebo (inactive pill) in 60 participants to see if it decreases how often or how severely freezing happens. Participants will take the study drug, complete walking assessments, and have brain scans to understand how the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboudumc
RECRUITINGNijmegen, Gelderland, 6525 GA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.